Instruction and Training for Handlers: Managing Assets with Implants
CW: dehumanisation, whump, living weapon, non-con drugging.
Dear Handler,
Congratulations. Your asset, [insert designation number], has been selected to be fitted with an implant. This is a significant milestone, indicating that the asset has reached a high enough rank and level of operational success to warrant the enhancement. Implants are cutting-edge devices embedded under the skin, typically near the shoulder blade, designed to monitor, control, and optimise the asset’s performance and compliance. These devices are integral to ensuring peak operational efficiency, extending mission endurance, and mitigating risks posed by physical or psychological limitations.
Understanding the Implant System
The implant uses real-time data to administer precise doses of performance-enhancing, pain-relieving, and compliance-inducing drugs. This system enables the asset to operate beyond normal human limits, ensuring mission success under the most demanding conditions. Additionally, the implant includes several failsafe measures to maintain control over the asset in high-stress or defection scenarios.
The implant is a cutting-edge biofeedback device designed for subdermal placement, typically near the shoulder blade. It represents the pinnacle of asset management technology, combining advanced monitoring, drug administration, and failsafe mechanisms in a compact, durable unit.
Design and Features
Sleek, Durable Structure The implant is encased in a lightweight, metallic alloy resistant to damage from environmental factors, including extreme temperatures, moisture, and impact. Its design ensures long-term reliability in harsh operational conditions.
Integrated Monitoring Systems The implant houses a network of sensors capable of real-time monitoring of vital signs, including heart rate, blood pressure, respiratory rate, brain activity, muscle tension, and more. Data is continuously transmitted to the facility’s control systems or the handler’s interface for remote observation.
Automated Drug Delivery Built-in reservoirs store a range of drugs, including stimulants, painkillers, regenerative treatments, and compliance agents—these reservoirs need regular monitoring and refilling. Micro-needles extend from the implant to administer precise doses directly into the bloodstream based on the asset’s physiological needs.
Visual Indicators The implant features subtle glowing elements (e.g., blue or green light) to indicate active monitoring or drug administration. These indicators can assist handlers in quickly assessing the implant's status during close interactions.
Failsafe Mechanisms The implant includes emergency protocols such as sedative bursts for asset incapacitation or a lethal dose for termination. These are accessible remotely by the handler or facility in critical situations.
Key Features
Vital Monitoring: Tracks critical metrics such as heart rate, respiratory rate, and brain activity.
Automated Drug Delivery: Administers stimulants, painkillers, and regenerative treatments based on the asset’s needs.
Emotional and Cognitive Regulation: Suppresses disobedience, reduces stress, or enhances focus.
Failsafes: Includes sedative bursts for asset incapacitation and lethal doses as a last resort.
Handler Responsibilities
As a handler, your primary responsibility is to utilize the implant's capabilities to maximize the asset’s performance while ensuring they remain compliant and functional. This involves:
1. Remote Monitoring and Control:
Although the implant is capable of functioning independently, administering doses based on biofeedback, you may also use the implant’s interface to monitor your asset’s condition and adjust their drug dosages as needed.
If your asset shows signs of fatigue, disobedience, or emotional instability, you are authorized to activate specific drug protocols.
2. Reward and Punishment Mechanisms:
The implant includes a reservoir of Euphoria-X, which can be used to reward compliance and exceptional performance.
Conversely, if the asset demonstrates disobedience or failure, sedative bursts or withdrawal-inducing drugs may be administered as corrective measures.
3. Communication and Conditioning:
Regularly reinforce the asset’s conditioning by pairing implant activations (e.g., reward or punishment) with verbal commands.
This strengthens their association between behavior and consequences, ensuring long-term compliance.
4. Failsafe Activation:
In extreme situations where the asset becomes a threat to themselves, their team, or the mission, you are authorized to initiate failsafe protocols. This includes sedative bursts to incapacitate or a lethal dose to terminate.
Key Reminders
Maintain the Illusion of Trust: Most assets believe the implant is a “reward” for their success. Reinforce this perception to reduce resentment and ensure compliance.
Minimize Dependency on Failsafes: Overusing sedatives or punitive measures can lead to long-term degradation of the asset’s mental stability. Reserve these for situations of critical disobedience.
Monitor for Overuse: Excessive reliance on performance enhancers or painkillers can result in addiction, burnout, and reduced efficiency. Ensure the asset is rotated out of high-stress missions when possible.
Protect Facility Interests: If an asset demonstrates patterns of instability or questions facility authority, inform your superior immediately. Assets with implants are highly valuable and highly dangerous.
By following these guidelines, you will ensure that your asset remains an efficient and compliant tool in service of the facility’s objectives.
